Pharma Journalist -

BioMarin Pharmaceutical Inc. and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a…
Read More...

Valneva SE a specialty vaccine company, today announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
Read More...

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the launch of the NAV3-33 Phase 3 clinical…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir tablets…
Read More...

Alpine Immune Sciences, Inc. and Horizon Therapeutics plc announced an exclusive license and collaboration agreement for the development and commercialization of up to four preclinical…
Read More...

SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd  March 2022 Workshop date: 23rd March 2022 Website:  www.parallel-trade.com/ Navigating…
Read More...

Merck, known as MSD outside the United States and Canada, announced the European Commission (EC) has approved VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for active…
Read More...

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for spesolimab for the…
Read More...

Rakuten Medical, Inc announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application to begin clinical studies of…
Read More...

Immatics N.V. a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, and Bristol Myers Squibb announced that…
Read More...